An intranasal flu vaccine approved two decades ago may have underappreciated immune benefits (opens in new tab)

For decades, influenza vaccines have been judged largely by the antibodies they generate in the bloodstream, a measure that has remained the gold standard since the first flu immunizations were administered in the 1940s.